| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| INDIRECT ACCOUNTING FEES | 1,062 |
| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| BIONANA GENOMICS INC | 2020-12 | PURCHASE | 2023-04 | 3,950 | 3,731 | 219 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| CORPORATE STOCK INVESTMENT | 205,790 | 129,314 |
| Item No. | 1 |
|---|---|
| Lender's Name | NOTE PAYABLE OFFICER |
| Lender's Title | |
| Original Amount of Loan | 9000 |
| Balance Due | 12500 |
| Date of Note | |
| Maturity Date | |
| Repayment Terms | ON DEMAND |
| Interest Rate | |
| Security Provided by Borrower | |
| Purpose of Loan | |
| Description of Lender Consideration | |
| Consideration FMV |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| EXPENSES | ||||
| FEES | 175 |